Kestra Medical Technologies KMTS
$25.10 −$1.53 (-5.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 0.00%
Open$26.14
Prev close$26.63
Day range$24.94 – $27.50
Volume435.1K
Market cap$1.50B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q1, ended Jul 2026
Revenue$30.97M+59.9% YoY
Operating profit-$37.66M-30.4% YoY
Net profit-$44.09M-70.7% YoY
Diluted EPS-$0.75-50.0% YoY
Free cash flow-$40.63M-17.6% YoY
Operating cash flow-$32.30M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin53.9%
Operating margin-134.5%
Net margin-140.4%
Return on equity-73.7%
Return on assets-48.8%
Return on invested capital-57.0%
Current ratio4.69
Liabilities / assets36.0%
Cash & investments$198.91M
Total debt$76.42M
Net cash (debt)$122.49M
Income statement
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $30.97M | $95.13M | $28.64M | $24.55M | $22.57M |
| Total Operating Revenue | $30.97M | $95.13M | $28.64M | $24.55M | $22.57M |
| Cost of Revenue | $13.47M | $46.26M | $12.96M | $11.65M | $11.14M |
| Gross Profit | $17.50M | $48.86M | $15.68M | $12.91M | $11.42M |
| Operating Expense | $55.16M | $183.60M | $55.03M | $47.67M | $43.18M |
| Selling and Admin Expenses | $48.36M | $164.12M | $49.39M | $42.70M | $38.30M |
| Research & Development | $6.80M | $19.48M | $5.63M | $4.97M | $4.88M |
| Operating Profit | -$37.66M | -$134.74M | -$39.34M | -$34.77M | -$31.76M |
| Net Non-Operating Interest Income (Expense) | $196,000.00 | $805,000.00 | $382,000.00 | $275,000.00 | -$105,000.00 |
| Non-Operating Interest Income | $2.13M | $8.35M | $2.23M | $2.16M | $1.80M |
| Non-Operating Interest Expense | $1.93M | $7.55M | $1.84M | $1.89M | $1.90M |
| Other Income (Expense) | -$6.58M | $2.62M | $319,000.00 | $359,000.00 | -$891,000.00 |
| Special Income (Charges) | -$6.30M | – | – | – | – |
| -Less:Other Special Charges | $6.30M | – | – | – | – |
| Other Non-Operating Income (Expenses) | -$272,000.00 | $2.62M | $319,000.00 | $359,000.00 | -$891,000.00 |
| Pretax Profit | -$44.04M | -$131.32M | -$38.64M | -$34.13M | -$32.75M |
| Tax | $50,000.00 | $294,000.00 | $192,000.00 | $35,000.00 | $34,000.00 |
| Net Profit | -$44.09M | -$131.61M | -$38.84M | -$34.17M | -$32.79M |
| Profit from Continuing Operations | -$44.09M | -$131.61M | -$38.84M | -$34.17M | -$32.79M |
| Net Income to Parent Company | -$44.09M | -$131.61M | -$38.84M | -$34.17M | -$32.79M |
| Net Income to Common Stockholders | -$44.09M | -$131.61M | -$38.84M | -$34.17M | -$32.79M |
| Basic EPS | -$0.75 | -$2.43 | -$0.67 | -$0.61 | -$0.64 |
| Diluted EPS | -$0.75 | -$2.43 | -$0.67 | -$0.61 | -$0.64 |
| Minority Interests | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Assets | $347.36M | $358.47M | $358.47M | $379.34M | $246.70M |
| Total Current Assets | $226.27M | $222.36M | $222.36M | $314.06M | $195.41M |
| Cash and Cash Equivalents & Short-Term Investments | $198.91M | $196.43M | $196.43M | $291.32M | $175.42M |
| -Cash and Cash Equivalents | $68.56M | $99.71M | $99.71M | $291.32M | $175.42M |
| -Short Term Investments | $130.35M | $96.72M | $96.72M | – | – |
| Receivables | $15.41M | $14.54M | $14.54M | $12.71M | $10.41M |
| -Accounts Receivable | $15.41M | $14.54M | $14.54M | $12.71M | $10.41M |
| Prepaid Assets | $2.39M | $1.69M | $1.69M | $1.71M | $1.30M |
| Inventory | $7.44M | $6.71M | $6.71M | $6.83M | $6.92M |
| Other Current Assets | $2.12M | $2.98M | $2.98M | $1.49M | $1.36M |
| Total Non-Current Assets | $121.08M | $136.11M | $136.11M | $65.28M | $51.29M |
| Net PPE | $66.92M | $62.45M | $62.45M | $57.22M | $47.89M |
| -Gross PPE | $100.78M | $93.88M | $93.88M | $86.69M | $75.66M |
| -Accumulated Depreciation | -$33.86M | -$31.43M | -$31.43M | -$29.48M | -$27.77M |
| Investments and Advances | $45.79M | $65.77M | $65.77M | – | – |
| Non-Current Prepaid Assets | $1.84M | $1.76M | $1.76M | $1.85M | $1.86M |
| Other Non-Current Assets | $6.53M | $6.12M | $6.12M | $6.21M | $1.54M |
| Total Liabilities | $125.00M | $98.81M | $98.81M | $91.35M | $82.62M |
| Total Current Liabilities | $48.27M | $50.37M | $50.37M | $42.93M | $35.76M |
| Payables | $25.96M | $27.30M | $27.30M | $24.02M | $20.21M |
| -Accounts Payable | $25.96M | $27.30M | $27.30M | $24.02M | $20.21M |
| Current Accrued Expenses | $15.00M | $9.11M | $9.11M | $8.66M | $7.19M |
| Short-Term Debt and Capital Lease Obligation | $23,000.00 | $31,000.00 | $31,000.00 | $10,000.00 | $53,000.00 |
| -Current Capital Lease Obligation | $23,000.00 | $31,000.00 | $31,000.00 | $10,000.00 | $53,000.00 |
| Total Non-Current Liabilities | $76.73M | $48.44M | $48.44M | $48.42M | $46.86M |
| Long Term Debt and Capital Lease Obligation | $76.42M | $46.76M | $46.76M | $46.54M | $44.75M |
| -Long Term Debt | $72.50M | $42.65M | $42.65M | $42.26M | $41.87M |
| -Long Term Capital Lease Obligation | $3.93M | $4.11M | $4.11M | $4.28M | $2.87M |
| Derivative Product Liabilities | $0.00 | $1.37M | $1.37M | $1.75M | $1.98M |
| Other Non-Current Liabilities | $306,000.00 | $306,000.00 | $306,000.00 | $140,000.00 | $140,000.00 |
| Total Equity | $222.36M | $259.66M | $259.66M | $287.99M | $164.08M |
| Stockholders' Equity | $222.36M | $259.66M | $259.66M | $287.99M | $164.08M |
| Capital Stock | $59.27M | $58.38M | $58.38M | $58.35M | $51.45M |
| -Common Stock | $59.27M | $58.38M | $58.38M | $58.35M | $51.45M |
| Additional Paid-In Capital | $859.50M | $853.35M | $853.35M | $842.67M | $691.49M |
| Retained Earnings | -$695.95M | -$651.86M | -$651.86M | -$613.03M | -$578.86M |
| Gains/Losses Not Affecting Retained Earnings | -$471,000.00 | -$218,000.00 | -$218,000.00 | – | – |
Cash flow
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$32.30M | -$81.70M | -$18.72M | -$18.37M | -$18.34M |
| Net cash flow from continuing operations | -$32.30M | -$81.70M | -$18.72M | -$18.37M | -$18.34M |
| Net Income from Continuing Operations | -$44.09M | -$131.61M | -$38.84M | -$34.17M | -$32.79M |
| Gain/Loss from Continuing Operations | $6.85M | -$1.51M | $58,000.00 | -$65,000.00 | $1.12M |
| Depreciation & Depletion & Amortization | $2.66M | $8.71M | $2.33M | $1.98M | $2.37M |
| Other Non-Cash Items | $511,000.00 | $2.20M | $521,000.00 | $594,000.00 | $555,000.00 |
| Change in Working Capital | -$7.50M | $1.78M | $4.93M | $2.12M | $711,000.00 |
| -Change in Receivables | -$48,000.00 | -$9.06M | -$2.91M | -$2.66M | -$1.71M |
| -Change in Inventory | -$908,000.00 | -$458,000.00 | $8,000.00 | $130,000.00 | -$136,000.00 |
| -Change in Prepaid Assets | $246,000.00 | -$563,000.00 | -$984,000.00 | -$532,000.00 | $813,000.00 |
| -Change in Payables and Accrued Expense | -$6.61M | $12.50M | $8.95M | $5.40M | $1.90M |
| -Change in Other Current Assets | $2,000.00 | $40,000.00 | $10,000.00 | $10,000.00 | $10,000.00 |
| -Change in Other Current Liabilities | -$190,000.00 | -$685,000.00 | -$144,000.00 | -$228,000.00 | -$175,000.00 |
| Net cash flow from investing | -$21.35M | -$203.28M | -$172.71M | -$14.92M | -$7.42M |
| Net Cash Flow from Continuing Investing Activities | -$21.35M | -$203.28M | -$172.71M | -$14.92M | -$7.42M |
| Net PPE Purchase and Sale | -$8.34M | -$35.42M | -$9.67M | -$9.99M | -$7.50M |
| Net Investment Purchase and Sale | -$13.02M | -$168.04M | -$163.04M | – | – |
| Financing Cash Flow | $22.50M | $147.10M | -$185,000.00 | $149.18M | -$27,000.00 |
| Net Cash Flow from Continuing Financing Activities | $22.50M | $147.10M | -$185,000.00 | $149.18M | -$27,000.00 |
| Net Issuance Payments Of Debt | $28.61M | – | – | – | – |
| Cash Dividends Paid | -$172,000.00 | -$323,000.00 | -$298,000.00 | -$25,000.00 | $0.00 |
| Proceeds from Stock Option Exercised | $2.44M | $593,000.00 | – | – | – |
| Net Other Financing Charges | -$8.38M | -$2.47M | -$480,000.00 | -$84,000.00 | -$27,000.00 |
| Ending Cash Balance | $68.89M | $100.04M | $100.04M | $291.66M | $175.76M |
| Net Change in Cash | -$31.15M | -$137.89M | -$191.61M | $115.90M | -$25.79M |
| Beginning Cash Balance | $100.04M | $237.93M | $291.66M | $175.76M | $201.55M |
| Free Cash Flow | -$40.63M | -$117.12M | -$28.39M | -$28.35M | -$25.84M |
| Deferred Tax | – | $166,000.00 | – | – | – |
| Net Other Investing Changes | – | $184,000.00 | $0.00 | $67,000.00 | $80,000.00 |
| Net Common Stock Issuance | – | $149.29M | $0.00 | – | – |
| Net Preferred Stock Issuance | – | $0.00 | $0.00 | $0.00 | – |
No comments yet — be the first to weigh in on KMTS.
Sign in to join the discussion.